TGF-β1/WISP1/Integrin-α interaction mediates human chondrocytes dedifferentiation

Area of Science:

• Cell biology
• Biochemistry
• Orthopedics

Background:

• Chondrocyte (CH) dedifferentiation is a key process in osteoarthritis (OA) pathogenesis.
• The roles of transforming growth factor-beta 1 (TGF-β1) and WISP1 in chondrocyte dedifferentiation are not fully understood.
• Integrin subunits α5 and αV may influence chondrocyte phenotype.

Purpose of the Study:

• To elucidate the interaction between TGF-β1 and WISP1 in chondrocyte dedifferentiation.
• To investigate the specific roles of Integrin α5 and αV subunits in WISP1-induced chondrocyte dedifferentiation.

Main Methods:

• Analysis of cartilage from OA and trauma patients using Western blotting for WISP1, Integrin α5/V, and collagen types I/II.
• In vitro studies involving isolated chondrocytes treated with TGF-β1 and WISP1.
• Manipulation of Integrin α5/V expression via siRNA and protein supplementation, followed by WISP1 treatment and analysis of chondrogenic/dedifferentiation markers (SOX9, type II collagen, type I collagen, Runx2) and cell proliferation (MTT assay).

Main Results:

• Osteoarthritis cartilage showed increased type I collagen, WISP1, Integrin α5, and Integrin αV, with decreased type II collagen.
• Upregulation of TGF-β1 led to increased WISP1, Integrin α5/V, and dedifferentiation markers.
• WISP1 upregulation promoted TGF-β1 expression and chondrocyte dedifferentiation; Integrin αV mediated WISP1-induced dedifferentiation, while Integrin α5 showed a protective effect.

Conclusions:

• TGF-β1 and WISP1 interact to induce chondrocyte dedifferentiation, primarily through Integrin αV.
• Integrin α5 plays a protective role against WISP1-induced chondrocyte dedifferentiation.
• The combined effect of TGF-β1 and WISP1 promotes chondrocyte proliferation independently of Integrin α5/V expression levels.